|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:1477-1484
© 2007 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Thoracic Service, Department of Surgery, Memorial Sloan–Kettering Cancer Center, New York, NY
b Department of Pathology, Memorial Sloan–Kettering Cancer Center, New York, NY
c Biostatistics Service, Department of Epidemiology–Biostatistics, Memorial Sloan–Kettering Cancer Center, New York, NY.
Read at the Eighty-seventh Annual Meeting of The American Association for Thoracic Surgery, Washington, DC, May 5-9, 2007.
Received for publication April 25, 2007; revisions received July 20, 2007; accepted for publication July 26, 2007. * Address for reprints: Nabil P. Rizk, MD, Thoracic Service, Department of Surgery, Memorial Sloan–Kettering Cancer Center, 1275 York Ave, New York, NY 10021. (Email: rizkn{at}mskcc.org).
Objective: Extended resections for advanced-stage thymomas are not commonly performed because of the potential morbidity in the face of unclear survival or palliative benefit. We reviewed our experience with multimodality treatment for Masaoka stage IVA thymomas for feasibility and outcomes.
Methods: We conducted a retrospective review of a single-institution surgical database. Data included patient demographics, preoperative staging and treatment, perioperative events, pathologic findings, and postoperative outcomes.
Results: During the period from 1996 to 2006, 18 patients who had Masaoka stage IVA thymoma underwent surgical resection. All patients received preoperative chemotherapy. Four patients with extensive pleural involvement underwent concomitant extrapleural pneumonectomy and postoperative hemithoracic radiation. Complete resection was achieved in 12 (67%) patients. There was no operative mortality. With a median follow-up of 32.2 months (range 1.4–129.9 months), 3-year, 5-year, and 10-year survivals were 91%, 78%, and 65%, respectively, and median survival has not yet been reached.
Conclusion: Multimodality therapy including extended surgical resection can be performed in select patients with stage IVA thymoma with low morbidity and mortality and can result in excellent long-term survival.
Related Article
J. Thorac. Cardiovasc. Surg. 2007 134: 1483-1484.
This article has been cited by other articles:
![]() |
M. J. Bott, H. Wang, W. Travis, G. J. Riely, M. Bains, R. Downey, V. Rusch, and J. Huang Management and Outcomes of Relapse After Treatment for Thymoma and Thymic Carcinoma Ann. Thorac. Surg., December 1, 2011; 92(6): 1984 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belcher, T. Hardwick, R. Lal, S. Marshall, J. Spicer, and L. Lang-Lazdunski Induction chemotherapy, cytoreductive surgery and intraoperative hyperthermic pleural irrigation in patients with stage IVA thymoma Interact CardioVasc Thorac Surg, May 1, 2011; 12(5): 744 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fabre, E. Fadel, S. Mussot, O. Mercier, B. Petkova, B. Besse, J. Huang, and P. G. Dartevelle Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymoma Eur J Cardiothorac Surg, May 1, 2011; 39(5): e133 - e138. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gonzalez, T. Krueger, J. Y. Perentes, O. Matzinger, S. Peters, and H.-B. Ris Extrapleural Pneumonectomy With Venous Confluence Resection for Stage IVA Thymic Tumors Ann. Thorac. Surg., March 1, 2011; 91(3): 941 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Ettinger, W. Akerley, G. Bepler, M. G. Blum, A. Chang, R. T. Cheney, L. R. Chirieac, T. A. D'Amico, T. L. Demmy, R. Govindan, et al. Thymic Malignancies* J Natl Compr Canc Netw, November 1, 2010; 8(11): 1302 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Okereke, K. A. Kesler, M. H. Morad, D. Mi, K. M. Rieger, T. J. Birdas, S. Badve, J. D. Henley, M. W. Turrentine, R. P. Nelson, et al. Prognostic Indicators After Surgery for Thymoma Ann. Thorac. Surg., April 1, 2010; 89(4): 1071 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cardillo, F. Carleo, R. Giunti, M. G. Lopergolo, L. Salvadori, A. R. De Massimi, L. Petrella, and M. Martelli Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa) Eur J Cardiothorac Surg, April 1, 2010; 37(4): 819 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, M. Anile, D. Diso, D. Vitolo, E. A. Rendina, T. De Giacomo, F. Francioni, and G. F. Coloni Thymoma and thymic carcinoma Eur J Cardiothorac Surg, January 1, 2010; 37(1): 13 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ishikawa, H. Matsuguma, R. Nakahara, H. Suzuki, A. Ui, T. Kondo, Y. Kamiyama, S. Igarashi, K. Mori, T. Kodama, et al. Multimodality Therapy for Patients With Invasive Thymoma Disseminated Into the Pleural Cavity: The Potential Role of Extrapleural Pneumonectomy Ann. Thorac. Surg., September 1, 2009; 88(3): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, N. P. Rizk, W. D. Travis, G. J. Riely, B. J. Park, M. S. Bains, J. Dycoco, R. M. Flores, R. J. Downey, and V. W. Rusch Comparison of patterns of relapse in thymic carcinoma and thymoma J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 26 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
Discussion J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 31 - 31. [Full Text] [PDF] |
||||
![]() |
S. Tomaszek, D. A. Wigle, S. Keshavjee, and S. Fischer Thymomas: Review of Current Clinical Practice Ann. Thorac. Surg., June 1, 2009; 87(6): 1973 - 1980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, G. J. Riely, K. E. Rosenzweig, and V. W. Rusch Multimodality Therapy for Locally Advanced Thymomas: State of the Art or Investigational Therapy? Ann. Thorac. Surg., February 1, 2008; 85(2): 365 - 367. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |